# A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

> **NCT07195916** · PHASE1 · RECRUITING · sponsor: **Incyte Corporation** · enrollment: 280 (estimated)

## Conditions studied

- Solid Tumors
- Hematologic Malignancies

## Interventions

- **DRUG:** INCA036873

## Key facts

- **NCT ID:** NCT07195916
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-08
- **Primary completion:** 2028-08-18
- **Final completion:** 2028-08-18
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07195916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07195916, "A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07195916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*